Skip to main content

GLP-1 drugs may reduce the risk of colorectal cancer

By NIH  
   January 09, 2024

Diabetics who took GLP-1 receptor agonists had a lower risk of colorectal cancer compared with those prescribed other diabetes drugs.

Full story


Get the latest on healthcare leadership in your inbox.